House Dust Mite Allergy Completed Phase 2 Trials for Vidutolimod (DB17500)

Also known as: Allergic Rhinitis Due to House Dust Mite / Allergy to House Dust / Allergy to House Dust Mite / Dust Mite Allergy / Allergy to dust mite protein (finding) / Allergic rhinitis caused by house dust mite (disorder) / House dust allergy / Allergy to house dust (finding) / Mite allergy

IndicationStatusPhase
DBCOND0033667 (House Dust Mite Allergy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00574223A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic RhinoconjunctivitisTreatment
NCT00574704A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic RhinoconjunctivitisTreatment